Gilead drugs Courtesy: media.licdn.com
19 February 2015

Examining the Gilead deal

Widely heralded as a success that brought together U.S. and Indian pharma producers over a high-cost drug at affordable prices, the Gilead deal looked ideal. A closer examination shows there’s more to consider than just low costs before the deal can become a template

China Long March 5 Courtesy: wantchinatimes.com
16 January 2015

Is India losing the tech race to China?

Economic development and increments in scientific knowledge and technology, which in turn rest on R&D, are interconnected. India is falling behind and must allocate a greater share to R&D, while China must elevate the efficiency of its research expenditure—this focus will allow the two countries to continue to grow

TCS Chennai office Courtesy: colorlibrary.blogspot.com
15 January 2015

Uruguayan touch to Indian tech

Even though the India-Latin America relationship is yet to realise its potential, there are unique initiatives bridging this gap. The landmark office of Tata Consultancy Services in Chennai, hailed for its energy efficiency, has been designed by two Uruguayan architects—an effort which represents the growing synergy

Darknet Courtesy: psychotropicon.info
6 January 2015

The ‘deep web’: new threat to business

Cyber crime has transcended hacking and other online illegal activities—the black markets of the “hidden” internet are now a potent threat. This “darknet” is used by illicit traders, saboteurs and terrorist groups—with serious financial and security implications for the Indian government and business sector

facebook-map Courtesy: Karen Bleier AFP/Getty
19 December 2014

Digital diplomacy

Social media has disrupted how diplomats communicate with each other and the general public. How are diplomats using these platforms? How will future digital tools change the meaning and capabilities of digital diplomacy? Gateway House presents an educational mini-series on digital diplomacy, profiling Indian digital diplomacy, and the future trajectory of digital diplomacy.

unnamed Courtesy: wikimedia
12 December 2014

‘India has capacity to meet global needs’

Earlier this year, Gilead Sciences, a California-based pharmaceutical company, made the headlines for an unusual, positive move in the fraught property rights space. It entered into a license agreement with seven Indian pharmaceutical companies to manufacture lower cost versions of Sovaldi, its popular Hepatitis C drug

Uber Courtesy: plus.google.com
12 December 2014

The rise of the Uber Empire

Uber’s success allowed it to raise close to $1.2 billion dollars in its last round of investments which means that even as technology changes lives and businesses break new ground, the balance between forging into the future and having an adaptive regulatory environment is the need of the hour

parliament Courtesy: Shahnoor Habib Munmum/Wikimedia Commons
10 January 2014

FDI pharma policy needs unusual answers

The issue of foreign direct investment in pharmaceuticals has come under attack from many lobbies. The answers lie in the public sector or public distribution mechanisms. Addressing public health concerns without vitiating the investment climate must be one of the key priorities of the next government